Effects of a mindfulness-based intervention (MYmind) for children with ADHD and their parents: protocol for a randomised controlled trial.
Study Goal
The researchers aimed to evaluate the effect of mindfulness-based group intervention on children with ADHD and their parents, comparing it to CBT in a randomized controlled trial.
Results Summary
The study design suggests potential benefits of mindfulness for children's attention, ADHD symptoms, behaviors, executive function, and mindfulness levels, as well as parental stress and well-being, but results are pending as the trial is pre-results.
Population
Children aged 8-12 years with ADHD and one of their parents (n=140 families).
Effective Dosage
8 weekly 90-minute group sessions for children and parents.
Duration
8 weeks, with follow-ups at 3 and 6 months post-intervention.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based group intervention | neutral | children's attention | children with ADHD | - | evaluate the effect | #1 |
mindfulness-based group intervention | neutral | ADHD-related symptoms | children with ADHD | - | evaluate the effect | #2 |
mindfulness-based group intervention | neutral | behaviours | children with ADHD | - | evaluate the effect | #3 |
mindfulness-based group intervention | neutral | executive function | children with ADHD | - | evaluate the effect | #4 |
mindfulness-based group intervention | neutral | mindfulness levels | children with ADHD | - | evaluate the effect | #5 |
mindfulness-based group intervention | neutral | parental stress | parents of children with ADHD | - | evaluate the effect | #6 |
mindfulness-based group intervention | neutral | parenting styles | parents of children with ADHD | - | evaluate the effect | #7 |
mindfulness-based group intervention | neutral | ADHD related symptoms | parents of children with ADHD | - | evaluate the effect | #8 |
mindfulness-based group intervention | neutral | well-being | parents of children with ADHD | - | evaluate the effect | #9 |
mindfulness-based group intervention | neutral | rumination level | parents of children with ADHD | - | evaluate the effect | #10 |
mindfulness-based group intervention | neutral | mindfulness levels | parents of children with ADHD | - | evaluate the effect | #11 |
INTRODUCTION: Mindfulness is one of the potential alternative interventions for children with attention-deficit hyperactivity disorder (ADHD). Some evidence suggests that mindfulness is related to changes in brain regions associated with ADHD. The potential benefits of mindfulness on children with ADHD, as well as the feasibility of this intervention approach, are warranted through prior local and foreign studies. This study aims to evaluate the effect of mindfulness-based group intervention for children with ADHD and their respective parents through a robust research design. METHODS AND ANALYSIS: This study will adopt a randomised controlled trial design including 140 children aged 8-12 years with ADHD together with one of their parents (n=140). These families will be randomised into intervention group (n=70) who will be offered the MYmind programme delivered by trained healthcare professionals, and an active control group (n=70) who will be offered the CBT programme. The intervention includes 8 weekly 90 min group sessions for children with ADHD (aged 8-12 years) and their respective parents. The primary and secondary outcomes will include children's attention, ADHD-related symptoms, behaviours, executive function and mindfulness levels measured by validated objective measures and parent's reported instruments. Parents' parental stress, parenting styles, ADHD related symptoms, well-being, rumination level and mindfulness levels will also be measured. Analysis is by intention to treat. The effects of intervention will be evaluated by comparing outcomes between the two arms, as well as comparing outcomes within subject through comparing measurements at baseline (T0), immediately after the 8 week intervention (T1) and at 3 (T2) and 6 (T3) months postintervention. ETHICS AND DISSEMINATION: Ethics approval has been granted by the Joint Chinese University of Hong Kong - New Territories East Cluster Clinical Research Ethics Committee (The Joint CUHK-NTEC CREC). Participants will be required to sign informed consent form from both parents and children. Findings will be reported in conferences and peer-reviewed publications in accordance with recommendations of Consolidated Standards of Reporting Trials. TRIAL REGISTRATION NUMBER: ChiCTR1800014741; Pre-results.